美波利祖马布
医学
内科学
人口
慢性阻塞性肺病
安慰剂
胃肠病学
置信区间
嗜酸性粒细胞
临床终点
哮喘
随机对照试验
病理
环境卫生
替代医学
作者
Ian Pavord,Pascal Chanez,Gerard J. Criner,Huib A.M. Kerstjens,Stephanie Korn,Njira Lugogo,Jean‐Benoît Martinot,Hironori Sagara,Frank C. Albers,Eric Bradford,Stephanie Harris,Bhabita Mayer,David Rubin,Steven W. Yancey,Frank C. Sciurba
标识
DOI:10.1056/nejmoa1708208
摘要
Patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.
科研通智能强力驱动
Strongly Powered by AbleSci AI